Literature DB >> 17554062

Lipid rafts are required for Kit survival and proliferation signals.

Thomas Jahn1, Erica Leifheit, Stacie Gooch, Simran Sindhu, Kenneth Weinberg.   

Abstract

In addition to its physiologic role as central regulator of the hematopoietic and reproductive systems, the Kit receptor tyrosine kinase (RTK) is pathologically overexpressed in some forms of leukemia and constitutively activated by oncogenic mutations in mast-cell proliferations and gastrointestinal stromal tumors. To gain insight into the general activation and signaling mechanisms of RTKs, we investigated the activation-dependent dynamic membrane distributions of wild-type and oncogenic forms of Kit in hematopoietic cells. Ligand-induced recruitment of wild-type Kit to lipid rafts after stimulation by Kit ligand (KL) and the constitutive localization of oncogenic Kit in lipid rafts are necessary for Kit-mediated proliferation and survival signals. KL-dependent and oncogenic Kit kinase activity resulted in recruitment of the regulatory phosphatidylinositol 3-kinase (PI3-K) subunit p85 to rafts where the catalytical PI3-K subunit p110 constitutively resides. Cholesterol depletion by methyl-beta-cyclodextrin prevented Kit-mediated activation of the PI3-K downstream target Akt and inhibited cellular proliferation by KL-activated or oncogenic Kit, including mutants resistant to the Kit inhibitor imatinib-mesylate. Our data are consistent with the notion that Kit recruitment to lipid rafts is required for efficient activation of the PI3-K/Akt pathway and Kit-mediated proliferation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17554062      PMCID: PMC1976347          DOI: 10.1182/blood-2006-05-020925

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Analysing c-kit internalization using a functional c-kit-EGFP chimera containing the fluorochrome within the extracellular domain.

Authors:  Thomas Jahn; Petra Seipel; Sunita Coutinho; Susanne Urschel; Kathleen Schwarz; Cornelius Miething; Hubert Serve; Christian Peschel; Justus Duyster
Journal:  Oncogene       Date:  2002-07-04       Impact factor: 9.867

2.  Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant.

Authors:  Michelle J Frost; Petranel T Ferrao; Timothy P Hughes; Leonie K Ashman
Journal:  Mol Cancer Ther       Date:  2002-10       Impact factor: 6.261

Review 3.  Functional rafts in cell membranes.

Authors:  K Simons; E Ikonen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

4.  Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.

Authors:  X Piao; R Paulson; P van der Geer; T Pawson; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.

Authors:  L Stephens; K Anderson; D Stokoe; H Erdjument-Bromage; G F Painter; A B Holmes; P R Gaffney; C B Reese; F McCormick; P Tempst; J Coadwell; P T Hawkins
Journal:  Science       Date:  1998-01-30       Impact factor: 47.728

6.  Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.

Authors:  S Hirota; K Isozaki; Y Moriyama; K Hashimoto; T Nishida; S Ishiguro; K Kawano; M Hanada; A Kurata; M Takeda; G Muhammad Tunio; Y Matsuzawa; Y Kanakura; Y Shinomura; Y Kitamura
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

7.  Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate.

Authors:  T F Franke; D R Kaplan; L C Cantley; A Toker
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

8.  Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase.

Authors:  Gunhild Sommer; Valter Agosti; Imke Ehlers; Ferdinand Rossi; Selim Corbacioglu; Judith Farkas; Malcolm Moore; Katia Manova; Cristina R Antonescu; Peter Besmer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

9.  Use of cyclodextrin for AFM monitoring of model raft formation.

Authors:  Marie-Cécile Giocondi; Pierre Emmanuel Milhiet; Patrice Dosset; Christian Le Grimellec
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

10.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.

Authors:  B J Druker; S Tamura; E Buchdunger; S Ohno; G M Segal; S Fanning; J Zimmermann; N B Lydon
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

View more
  29 in total

1.  Complex chemoattractive and chemorepellent Kit signals revealed by direct imaging of murine mast cells in microfluidic gradient chambers.

Authors:  Amir Shamloo; Milan Manchandia; Meghaan Ferreira; Maheswaran Mani; Christopher Nguyen; Thomas Jahn; Kenneth Weinberg; Sarah Heilshorn
Journal:  Integr Biol (Camb)       Date:  2013-08       Impact factor: 2.192

2.  PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains.

Authors:  Xinxin Gao; Pamela R Lowry; Xin Zhou; Charlene Depry; Zhikui Wei; G William Wong; Jin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

3.  Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT.

Authors:  Sabrina Brahimi-Adouane; Jean-Baptiste Bachet; Séverine Tabone-Eglinger; Frédéric Subra; Claude Capron; Jean-Yves Blay; Jean-François Emile
Journal:  Mol Oncol       Date:  2012-10-30       Impact factor: 6.603

Review 4.  Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking.

Authors:  M Z Ratajczak; M Adamiak
Journal:  Leukemia       Date:  2015-03-09       Impact factor: 11.528

5.  PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability.

Authors:  Yasuko Furumoto; Nicolas Charles; Ana Olivera; Wai Hang Leung; Sandra Dillahunt; Jennifer L Sargent; Kevin Tinsley; Sandra Odom; Eric Scott; Todd M Wilson; Kamran Ghoreschi; Manfred Kneilling; Mei Chen; David M Lee; Silvia Bolland; Juan Rivera
Journal:  Blood       Date:  2011-09-16       Impact factor: 22.113

6.  Interaction between activated chemokine receptor 1 and FcepsilonRI at membrane rafts promotes communication and F-actin-rich cytoneme extensions between mast cells.

Authors:  Nimita H Fifadara; Freddy Beer; Shoichiro Ono; Santa J Ono
Journal:  Int Immunol       Date:  2010-02       Impact factor: 4.823

Review 7.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms.

Authors:  Glenn Cruse; Dean D Metcalfe; Ana Olivera
Journal:  Immunol Allergy Clin North Am       Date:  2014-03-12       Impact factor: 3.479

9.  Wiskott-Aldrich syndrome protein is an effector of Kit signaling.

Authors:  Maheswaran Mani; Shivkumar Venkatasubrahmanyam; Mrinmoy Sanyal; Shoshana Levy; Atul Butte; Kenneth Weinberg; Thomas Jahn
Journal:  Blood       Date:  2009-07-30       Impact factor: 22.113

10.  Inhibition of HMG CoA reductase reveals an unexpected role for cholesterol during PGC migration in the mouse.

Authors:  Jiaxi Ding; Dechen Jiang; Michael Kurczy; Jennifer Nalepka; Brian Dudley; Erin I Merkel; Forbes D Porter; Andrew G Ewing; Nicholas Winograd; James Burgess; Kathleen Molyneaux
Journal:  BMC Dev Biol       Date:  2008-12-31       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.